EA201400571A1 - Специфичные к трансресвератролу антитела и их применение - Google Patents

Специфичные к трансресвератролу антитела и их применение

Info

Publication number
EA201400571A1
EA201400571A1 EA201400571A EA201400571A EA201400571A1 EA 201400571 A1 EA201400571 A1 EA 201400571A1 EA 201400571 A EA201400571 A EA 201400571A EA 201400571 A EA201400571 A EA 201400571A EA 201400571 A1 EA201400571 A1 EA 201400571A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibody
transresverotrol
antibodies
specific
application
Prior art date
Application number
EA201400571A
Other languages
English (en)
Inventor
Иван Петяев
Валерий Цыбезов
Original Assignee
АйПи САЙЕНС ЛИМИТЕД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АйПи САЙЕНС ЛИМИТЕД filed Critical АйПи САЙЕНС ЛИМИТЕД
Publication of EA201400571A1 publication Critical patent/EA201400571A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Настоящее изобретение предоставляет способ обнаружения или измерения трансресвератрола (tRV) в образце, включающий контактирование предназначенного для тестирования образца с антителом к tRV или антигенсвязывающим фрагментом такого антитела и обнаружение или измерение tRV, связанного с этим антителом или фрагментом антитела. Изобретение также предоставляет антитело к трансресвератролу.
EA201400571A 2011-11-11 2012-11-09 Специфичные к трансресвератролу антитела и их применение EA201400571A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1119585.6A GB201119585D0 (en) 2011-11-11 2011-11-11 Assay
PCT/GB2012/052790 WO2013068758A1 (en) 2011-11-11 2012-11-09 Antibody specific for trans - resveratrol and use thereof

Publications (1)

Publication Number Publication Date
EA201400571A1 true EA201400571A1 (ru) 2014-11-28

Family

ID=45444075

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400571A EA201400571A1 (ru) 2011-11-11 2012-11-09 Специфичные к трансресвератролу антитела и их применение

Country Status (8)

Country Link
US (2) US9547001B2 (ru)
EP (1) EP2776464B1 (ru)
CN (1) CN104093737B (ru)
AU (1) AU2012335353B2 (ru)
CA (1) CA2856200A1 (ru)
EA (1) EA201400571A1 (ru)
GB (1) GB201119585D0 (ru)
WO (1) WO2013068758A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150005391A1 (en) 2013-06-26 2015-01-01 COLE Research & Design, Inc. Method of reducing scarring
CN105418412B (zh) * 2014-09-17 2018-07-06 中国人民解放军军事医学科学院毒物药物研究所 降糖活性化合物及其医药用途
US10099995B2 (en) 2015-12-24 2018-10-16 Cole Research and Design, LLC Resveratrol esters
CA3043398A1 (en) 2016-11-10 2018-05-17 Ivan Petyaev Functional chocolate
WO2018164662A1 (en) * 2017-03-06 2018-09-13 Elsohly Mahmoud A Resveratrol esters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772444B2 (en) 2005-05-19 2010-08-10 E. I. Du Pont De Nemours And Company Method for the production of resveratrol in a recombinant oleaginous microorganism
RU2385457C1 (ru) * 2008-10-31 2010-03-27 Государственное образовательное учреждение высшего профессионального образования "Белгородский государственный университет" Способ идентификации резвератрола

Also Published As

Publication number Publication date
CA2856200A1 (en) 2013-05-16
HK1197248A1 (en) 2015-01-09
CN104093737A (zh) 2014-10-08
EP2776464B1 (en) 2016-09-28
AU2012335353B2 (en) 2016-11-17
AU2012335353A1 (en) 2014-05-29
US9547001B2 (en) 2017-01-17
CN104093737B (zh) 2017-11-21
US20170146524A1 (en) 2017-05-25
US20140349319A1 (en) 2014-11-27
GB201119585D0 (en) 2011-12-28
WO2013068758A1 (en) 2013-05-16
EP2776464A1 (en) 2014-09-17

Similar Documents

Publication Publication Date Title
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
MX358772B (es) Metodo para detectar cancer.
MX2014001377A (es) Metodo para detectar cancer pancreatico.
MX366275B (es) Metodos para detectar y medir la agregacion.
EA201692242A1 (ru) Композиции с высокой концентрацией антител
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
EA201790664A1 (ru) Антитела против мезотелина и иммуноконъюгаты
ECSP088081A (es) Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
IN2014CN02113A (ru)
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
BR112012019475A8 (pt) uso de um anticorpo monoclonal anti-cd44, anticorpo monoclonal anti-cd44, anticorpo anti-cd44 humanizado e kit para a detecção da presença de hnscc em uma amostra
EP3165560A4 (en) Resin-metal composite, labeling substance, immunoassay method, immunoassay reagent, method for measuring analyte, analyte measurement kit, and lateral-flow chromatographic test strip
BR112016007037A2 (pt) método para detectar câncer pancreático, anticorpo monoclonal e kit
WO2014144725A3 (en) Melatonin monoclonal antibody, detection, methods and uses thereof
CR20110530A (es) Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas
TR201819828T4 (tr) Anti-fosfolipaz d4 antikoru.
RU2015104737A (ru) Способ обнаружения мультиспецифического связывающего агента
AR089233A1 (es) Determinacion de autoanticuerpos en condiciones de baja conductividad y sensibilidad aumentada
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
BR112013004594A2 (pt) método para a determinação de um conteúdo de antígeno
EA201400356A1 (ru) Иммуноанализ для обнаружения антибиотиков
EA201692071A1 (ru) Иммуноанализ и антитела для обнаружения хромогранина а
WO2013167727A3 (en) Method for determining arthritis relapse risk